Cargando…
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
Accumulation of α-synuclein (α-Syn) is a remarkable pathology for Parkinson’s disease (PD), therefore clearing it is possibly a promising strategy for treating PD. Aberrant copper (Cu(II)) homeostasis and oxidative stress play critical roles in the abnormal aggregation of α-Syn in the progress of PD...
Autores principales: | Teng, Yilong, Zhao, Juan, Ding, Lulu, Ding, Yu, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719089/ https://www.ncbi.nlm.nih.gov/pubmed/31416122 http://dx.doi.org/10.3390/molecules24162940 |
Ejemplares similares
-
The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation
por: Sternke-Hoffmann, Rebecca, et al.
Publicado: (2020) -
Synthesis and Cytotoxic Evaluation of Steroidal Copper (Cu (II)) Complexes
por: Huang, Yanmin, et al.
Publicado: (2017) -
Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α‐Synuclein
por: Teng, Xiangyu, et al.
Publicado: (2021) -
EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’ of α-Synuclein
por: Yang, Jee Eun, et al.
Publicado: (2017) -
Inhibitory Effect of Curcumin-Cu(II) and Curcumin-Zn(II) Complexes on Amyloid-Beta Peptide Fibrillation
por: Banerjee, Rona
Publicado: (2014)